Baqsimi
NDC 0548-8351, glucagon, powder, from Amphastar Pharmaceuticals, Inc..
- Product NDC
- 0548-8351
- Status
- Listed
- Labeler
- Amphastar Pharmaceuticals, Inc.
- Dosage form
- POWDER
- Route
- NASAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210134
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0548-8351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLUCAGON3 mg/1
Pharmacologic classes
Antihypoglycemic Agent [EPC]; Decreased GI Motility [PE]; Decreased GI Smooth Muscle Tone [PE]; Decreased Glycolysis [PE]; Gastrointestinal Motility Inhibitor [EPC]; Increased Gluconeogenesis [PE]; Increased Glycogenolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0548-8351-01 | 00548835101 | 1 TUBE in 1 CARTON (0548-8351-01) / 1 BOTTLE, UNIT-DOSE in 1 TUBE / 1 POWDER in 1 BOTTLE, UNIT-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f1f5df9b-872f-44e5-a18f-f0b68e7e9254NADAC price for package 00548835101
GET /v1/drugs/nadac/00548835101
Use it
Look up 0548-8351 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0548-8351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0548-8351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.